Skip to content

Arthrex® AR-1540BCRecalls & reported problems

Arthrex, Inc. · TENODESIS SCREW, BIOCOMPOSITE · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
8
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 8 adverse event reports that list this exact device (DI 00888867018709), received between Aug 23, 2018 and Apr 6, 2026 — classified as 2 injuries, 6 malfunctions.

The most frequently reported specific device problem is “Break” (5 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 1 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Break5
  • Appropriate Device Problem Term/Code Not Available1
  • Fitting Problem1
  • Insufficient Device Problem Information1

Patient problems

  • Insufficient Information4
  • No Clinical Signs, Symptoms or Conditions3
  • Erythema1
  • Failure of Implant1
  • No Code Available1
  • Swelling1

Recent adverse event reports

The 8 most recent of 8 reports, in the reporter's own words as published by the FDA.

  • MalfunctionApr 6, 2026Break

    ON 13-MAR-2026, A FACILITIES REPRESENTATIVE REPORTED VIA PHONE THAT AN AR-1540BC BIOCOMPOSITE TENODESIS SCREW FELL APART WHEN TAPPED AT THE INITIAL POINT OF INSERTION DURING AN OPEN REDUCTION AND INTERNAL FIXATION OF A SCAPHOID FRACTURE. ALL FRAGMENTS WERE RETRIEVED, AND A NEW DEVICE WAS OPENED TO COMPLETE THE CASE WITH A MINIMAL TIME DELAY.

    Patient problems: Insufficient Information

    MAUDE report 24793544 ↗
  • MalfunctionOct 12, 2023Fitting Problem; Fitting Problem

    ON 9/15/2023, IT WAS REPORTED BY A SALES REPRESENTATIVE VIA PHONE THAT AN AR-1540BC BIOCOMPOSITE-TENODESIS SCREW 4 X 10 MM HAD AN ISSUE. DURING A CARPAL METACARPAL ARTHROPLASTY PROCEDURE ON (B)(6) 2023, WHEN THE SURGEON WAS TRYING TO IMPLANT THE SCREW, IT WAS NOT AS TIGHT OF A FIT AS PREFERRED, AND THE DEVICE WOULD NOT SEAT CORRECTLY. THE SCREW WAS REMOVED IN ONE PIECE, NOTHING BROKE INSIDE THE PATIENT, AND A MINI TIGHTROPE IMPLANT SYSTEM WITH AN UNKNOWN PART AND LOT NUMBER WAS USED TO COMPLETE THE PROCEDURE SUCCESSFULLY. THERE WAS NO CASE DELAY AND NO HARM TO THE PATIENT. THE SCREW WAS DISCARDED BY THE FACILITY, NO PICTURES WERE TAKEN. THIS OCCURRED DURING USE WITH NO PATIENT HARM.

    Patient problems: Failure of Implant; No Clinical Signs, Symptoms or Conditions

    MAUDE report 17920628 ↗
  • MalfunctionDec 7, 2022Break

    ON (B)(6) 2022, IT WAS REPORTED BY A FACILITY REPRESENTATIVE VIA EMAIL THAT AR-1540BC BIO-COMPOSITE-TENODESIS¿ SCREW BROKE DURING INSERTION. THE SURGEON REMOVED ALL FRAGMENTS AND COMPLETED THE CASE WITH A NEW ONE. THIS WAS DISCOVERED DURING A PROCEDURE ON (B)(6) 2022.

    Patient problems: Insufficient Information; No Clinical Signs, Symptoms or Conditions

    MAUDE report 15931157 ↗
  • MalfunctionJun 27, 2022Break

    ON 6/13/2022, IT WAS REPORTED BY AN ARTHREX EMPLOYEE VIA EMAIL THAT AN AR-1540BC BIO-COMPOSITE-TENODESIS SCREW BROKE DURING INSERTION. SURGEON WAS ABLE TO RETRIEVE ALL BROKEN FRAGMENTS. THIS WAS DISCOVERED DURING AN ANKLE SIDE INSTABILITY PROCEDURE ON (B)(6) 2022.

    Patient problems: Insufficient Information

    MAUDE report 14829167 ↗
  • MalfunctionApr 20, 2021Break

    IT WAS REPORTED THAT DURING A BIO TENODESIS, THE AR-1540BC, BROKE WHEN THE SURGEON WAS PLACING IT INTO THE PATIENT'S BONE. THE FRAGMENT WAS REMOVED AND THE CASE WAS COMPLETED BY USING A NEW AR-1540BC.

    Patient problems: Insufficient Information

    MAUDE report 11692634 ↗
  • MalfunctionFeb 22, 2021Break

    IT WAS REPORTED THAT DURING A DEX PROCEDURE, WHEN THE SURGEON WAS USING THE AR-1540BC, THE ANCHOR BROKEN. SINCE THE ANCHOR BROKE, THE SURGEON DECIDED TO REMOVE ALL FRAGMENTS AND USE A TENODESIS SCREW INSTEAD WITHOUT FURTHER ISSUE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 11358007 ↗
  • InjuryDec 13, 2018Appropriate Device Problem Term/Code Not Available

    DURING SOCIAL SAFEGUARD CYBER REVIEW A CONVERSATION WAS DISCOVERED WHICH MENTIONED A HAMMERTOE REVISION PROCEDURE. UPON FURTHER INVESTIGATION IT WAS DISCOVERED THAT A PATIENT HAD UNDERGONE A REVISION SURGERY ON (B)(6) 2018. DURING THE REVISION PROCEDURE THE SURGEON EXPLANTED AN AR-1540BC, BIO-COMPOSITE TENODESIS SCREW. THE EXPLANTED SCREW WAS FULLY INTACT, WAS REMOVED AND DISCARDED AT TIME OF PROCEDURE. ONCE THE SCREW WAS REMOVED THE SURGEON FILLED THE VOID WITH 1 CC OF ALLOSYNC PUTTY AND THEN PLACED STAPLES. THE REASON FOR PERFORMING THE REVISION AND REMOVING THE SCREW IS BECAUSE THE SURGEON EXPRESSED CONCERN ABOUT POOR BONE QUALITY. SURGEON PROVIDED NO FURTHER INFORMATION TO THE SALES REP WITH REGARD TO THE REVISION. THE ORIGINAL PROCEDURE WAS PERFORMED BY A DIFFERENT SURGEON IN A DIFFERENT CITY AND FURTHER DETAILS FROM THAT PROCEDURE ARE NOT AVAILABLE.

    Patient problems: No Code Available

    MAUDE report 8160323 ↗
  • InjuryAug 23, 2018Insufficient Device Problem Information

    IT WAS REPORTED THAT ON (B)(6) 2018 THE PATIENT UNDERWENT A CARPAL-META CARPAL FASCIA ARTHROPLASTY WITH LIGAMENT RECONSTRUCTION PROCEDURE WHERE A BIOCOMPOSITE-TENODESIS¿ SCREW 4 X 10 MM, AR-1540BC, WAS IMPLANTED. ABOUT 5 WEEKS POST-OP, THE PATIENT BEGAN TO EXPERIENCE REDNESS AND SWELLING AT THE INCISION SITE. THE PATIENT WAS HOSPITALIZED AND TREATED WITH IV ANTIBIOTICS. THE SUTURE USED IN THE SURGERY WAS FROM ETHICON. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: Erythema; Swelling

    MAUDE report 7809849 ↗

Other Screw, fixation, bone devices

All Screw, fixation, bone devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page